Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jun;57(12):1469-1470.
doi: 10.1111/apt.17439.

Editorial: golimumab dosing intensification effective in ulcerative colitis with no need for therapeutic drug monitoring

Jurij Hanzel  1   2 , David Drobne  1   2
Affiliations
Editorial

Editorial: golimumab dosing intensification effective in ulcerative colitis with no need for therapeutic drug monitoring

Jurij Hanzel et al. Aliment Pharmacol Ther. 2023 Jun.
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

REFERENCES

    1. Sandborn WJ, Feagan BG, Marano C, Zhang H, Strauss R, Johanns J, et al. Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology. 2014;146(1):85-95.
    1. Sandborn WJ, Feagan BG, Marano C, Zhang H, Strauss R, Johanns J, et al. Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis. Gastroenterology. 2014;146(1):96-109.
    1. Armuzzi A, DiBonaventura MD, Tarallo M, Lucas J, Bluff D, Hoskin B, et al. Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe. PloS One. 2020;15(1):e0227914.
    1. Burr NE, Gracie DJ, Black CJ, Ford AC. Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis. Gut. 2022;71(10):1976-87.
    1. Philip G, Cornillie F, Adedokun JO, Melsheimer R, Rutgeerts P, Colombel JF, et al. Early dose optimisation of Golimumab in nonresponders to induction treatment for ulcerative colitis is effective and supported by pharmacokinetic data. J Crohn's Colitis. 2019;13(10):1257-64.

MeSH terms

LinkOut - more resources